ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.04159
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,577.83
0.14%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Petros Pharmaceuticals Inc (PTPI)

  7. Petros Pharmaceuticals Inc (PTPI) Noticias

PTPI

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PTPI
FechaHoraFuenteTítuloSímboloCompañía
31/05/202416:07Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
20/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
14/05/202406:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202415:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202316:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202315:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202316:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202316:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202315:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202316:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202316:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202315:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202315:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
22/12/202216:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202207:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202206:03Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:PTPIPetros Pharmaceuticals Inc
21/10/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTPIPetros Pharmaceuticals Inc
14/10/202215:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/10/202216:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
30/09/202215:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/08/202216:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202210:39GlobeNewswire Inc.NOTICE TO DISREGARD - Henry Crown and CompanyNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202209:27GlobeNewswire Inc.Petros Pharmaceuticals Responds to Fraudulent Press ReleaseNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202208:25GlobeNewswire Inc.Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per shareNASDAQ:PTPIPetros Pharmaceuticals Inc
19/07/202208:15GlobeNewswire Inc.Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew PinskyNASDAQ:PTPIPetros Pharmaceuticals Inc
16/05/202216:00GlobeNewswire Inc.Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:PTPIPetros Pharmaceuticals Inc
03/05/202208:23GlobeNewswire Inc.Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the USNASDAQ:PTPIPetros Pharmaceuticals Inc
27/04/202220:25GlobeNewswire Inc.Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022NASDAQ:PTPIPetros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTPI

Su Consulta Reciente

BIT
P209L9
NLBNPIT209L9 20991231 3....
BIT
F14621
Vontobel Financial Produ...
BIT
P1XBJ2
NLBNPIT1XBJ2 20351219 10...
BIT
P1U0J8
NLBNPIT1U0J8 20240621 520
LSE
SG84
Citi Fun 25
BIT
UV8C7T
UniCredit Bank
BIT
UC5630
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados